
CAR-T cell therapy for myasthenia gravis
CAR-T cell therapy has established itself as an effective treatment option in hemato-oncology, particularly for B-cell lymphomas. Due to its targeted mechanism of action, it is also increasingly being used for autoimmune diseases.







